Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Hate Big Pharma all you like, it still might save your life
In May, Eli Lilly announced clinical trials for a gene-editing treatment that dramatically lowers bad cholesterol, one of the primary drivers of heart disease. The technology permanently alters a gene in the liver that acts as a brake on the body's…
Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs
Pharma Equity Group prevails in international arbitration proceedings and is awarded EUR 10.5 million excluding interest and costs Pharma Equity Group A/S ('PEG' or the 'Company') today announces that it has received a final and binding…
Teva's Biosimilar Boom Is Just Getting Started. Is It Time to Buy This Rebounding Pharma Stock?
Teva Pharmaceutical Industries (TEVA +0.20%) has clawed back from the brink like few drugmakers have. After a long stretch of poor performance, a company once buried under debt, patent cliffs, and litigation is now up by 97% in the last 12 months.
Cypriot pharma leader Medochemie celebrates five decades of expansion
Medochemie marked its 50th anniversary in 2026, reflecting on a journey that transformed a Limassol-based start-up into a global pharmaceutical exporter built on vision, innovation and sustained international expansion. Behind five decades of…
Castleark Management LLC Increases Position in Ascendis Pharma A/S $ASND
Castleark Management LLC increased its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 55.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned…
Rhenman & Partners Asset Management AB Purchases New Shares in Ascendis Pharma A/S $ASND
Rhenman & Partners Asset Management AB purchased a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased…
Rhenman & Partners Asset Management AB Decreases Stock Holdings in Royalty Pharma PLC $RPRX
Rhenman & Partners Asset Management AB trimmed its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 206,500 shares…
Drugmakers race to find a place in the next wave of obesity drugs
Eli Lilly, Novo Nordisk, Amgen, Zealand, Structure Therapeutics shared their visions for the future of obesity medicine. Drugmakers pitched doctors and investors on their future drugs at the recent American Diabetes Association (ADA) Scientific…
Teva Pharmaceutical Industries Ltd. $TEVA Shares Acquired by Clal Insurance Enterprises Holdings Ltd
Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 18.8% in the fourth quarter, according to the company in its most recent filing with the Securities and…
Maine disables data breach notification portal after fake disclosures
Maine has taken its public data breach reporting portal offline after fraudulent breach disclosures were published on the state's website, prompting a review of procedures to prevent abuse in the future. Yesterday, BleepingComputer reported that…
India's productivity gap with China widens despite strong GDP growth: Equirus Securities
India's labour productivity gap with China has widened by more than $30,000 per worker since 2000, despite decades of strong economic growth, with the country yet to achieve the industry-led productivity transformation seen in economies such as…
Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years
Paying $2,000 a month in rent is often described as throwing money away. Homeownership, by contrast, is treated as the only reliable path to wealth. Yet under the right conditions, a dividend portfolio large enough to cover your rent can leave you…
State Street Corp Has $7.48 Billion Stock Position in Pfizer Inc. $PFE
State Street Corp raised its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 0.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 300,445,164 shares of the biopharmaceutical company's stock…
Van ECK Associates Corp Sells 4,813,780 Shares of Pfizer Inc. $PFE
Van ECK Associates Corp trimmed its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 26.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,342,760…
Pfizer (NYSE:PFE) Cut to 'Hold' at Wall Street Zen
Pfizer (NYSE:PFE - Get Free Report) was downgraded by analysts at Wall Street Zen from a 'buy' rating to a 'hold' rating in a research note issued to investors on Saturday. Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion A number of…
Receive a Daily briefing on Pharma Industry News
Get Started